This five-day computational course aims to give molecular microbiologists working with bacterial and eukaryotic pathogens a working knowledge of genomic analysis. The course will take the form of a series of modules covering the fundamental aspects of DNA sequence analysis and exploitation.
Sequence data from whole genomes let researchers track the spread of strains worldwide.
The goal of this Keystone Symposia conference is to bring together those developing and studying genome engineering tools with groups who are applying them to build new disease models, identify disease mechanisms and drug targets, and develop cell-based therapeutics and genetic medicines. In addition to covering engineering of human and animal cells, this conference will also highlight the emerging field of genome engineering to identify new anti-microbial and anti-viral drugs and applications toward next-generation antibiotics.
The researchers deployed computer programs to pinpoint the pathogenic virus in this mountain of genetic data. Using deep bioinformatic processing, they successfully identified parts of the pathogen's genetic profile and compared them to the profiles of known viruses.
In the first attempt of its kind, researchers plan to sequence all known species of eukaryotic life in a single country, the United Kingdom. The announcement was made at the official launch of a $4.7 billion global effort, called the Earth BioGenome Project, to sequence the genomes of all of Earth’s known 1.5 million species of eukaryotes within a decade.
Researchers have unveiled a new system, based on machine learning models, that identifies patterns in the genomes of viruses to offer a hypothesis about their hosts and vectors.
Rice University scientist's study finds growth of genomic databases affects species accuracy.
In a historic first, a group of CDC laboratory and bioinformatics scientists became the first to directly sequence an RNA genome. They did so with the RNA genomes of five influenza (Flu) A viruses, including seasonal influenza A and avian influenza A viruses.
With the coming of the 21st century, biology has emerged as the vanguard of the scientific enterprise and computing as the epicenter of engineering and technology.
New innovations and technologies will result in vaccines becoming even more efficient and playing a greater role in disease prevention.